Many who have schizophrenia don’t respond to antipsychotic drugs. That’s why experts are cheering the US Food and Drug ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

Following a formal dossier validation period, the HPFB may complete the review of a new drug candidate within 300 days. In 2023 CLINUVEL announced that the first Canadian EPP patient had received ...

Jamie Alan, PhD, an associate professor of pharmacology and toxicology at Michigan State University, agrees. “Lowering blood sugar would theoretically help dementia, particularly vascular dementia,” ...